Dermapharm Holding SE (WBO:DMP) FFO per Share


WBO:DMP Dermapharm Holding SE WBO:DMP
39 GF Score
Price €47.05
GF Value €38.40
! 9 Warning Signs
View Full Analysis

What is Dermapharm Holding SE FFO per Share?

FFO per Share only applies to REITs.

WBO:DMP
39GF Score
Dermapharm Holding SE WBO:DMP
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Dermapharm Holding SE (WBO:DMP) Overvalued in 2026?

Based on GuruFocus' analysis, Dermapharm Holding SE stock appears to be overvalued. The current stock price of €47.05 is trading 22.5% above its estimated GF Value™ of €38.40.

Key valuation signals for WBO:DMP:

  • FFO per Share:
  • GF Value™: €38.40 vs. price of €47.05 (22.5% above fair value)
  • GF Score™: 39/100 with 9 warning signs

No single metric tells the full story. See the WBO:DMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dermapharm Holding SE Business Description

Address Lil-Dagover-Ring 7, Grunwald, BY, DEU, 82031
Dermapharm Holding SE manufactures patent-free branded pharmaceuticals for selected therapy fields, over-the-counter drugs, and natural remedies. The portfolio of the company includes cosmetics, nutritional supplements, and diet and medical devices. Business operating segments include Branded pharmaceuticals, which drive key revenue, Other healthcare products, and Parallel import business. The Branded pharmaceuticals segment covers numerous product areas through a wide variety of items sold under reputable brand names.
39GF Score

Get the complete analysis for WBO:DMP

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€47.05
Price
€38.40
GF Value